Procedure Expectations and Prep

Short procedure, lasting results

YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is administered by an eye doctor during a simple in-office procedure and is designed to deliver a low dose of steroid for up to 36 months.

What to expect from the procedure

BEFORE your treatment begins, your eyelid is held open with a device called a speculum, your eye is numbed with drops, and a topical antiseptic is applied to the eye.

DURING your procedure, the YUTIQ implant will be inserted with a tiny needle. As the implant is injected, you may feel pressure on your eye.

AFTER your procedure, your eye will be monitored for possible side effects, such as increased pressure in your eye, right after the implant is inserted and then again 2 to 7 days as directed by your doctor.

It’s important to keep up with your appointments so your eye doctor can carefully monitor your condition.

You may experience temporary visual blurring after receiving the YUTIQ injection. DO NOT drive or use machinery until this has been resolved. It is recommended that you bring a caregiver or family member to your procedure to drive you home afterward.

Talk with your retina or uveitis specialist about treatment with YUTIQ. Don’t have one?

Find one here

Questions to ask
your doctor about
YUTIQ

Find an eye doctor

Watch real patients
describe their
YUTIQ journey

When I was told YUTIQ could last up to 3 years, I jumped at the opportunity.

– David, a YUTIQ patient

One patient’s experience; individual results may vary.

NEXT: Frequently
Asked Questions

NEXT: Frequently Asked Questions

INDICATION AND IMPORTANT SAFETY INFORMATION

Indication

YUTIQ® contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

Important Safety Information

Do not take YUTIQ if:

  • You have, or suspect you have, an eye infection.
  • If you have been told you are allergic to any of the ingredients in YUTIQ.

Indication

YUTIQ® contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

Important Safety Information

Do not take YUTIQ if:
  • You have, or suspect you have, an eye infection.
  • If you have been told you are allergic to any of the ingredients in YUTIQ.
YUTIQ may cause serious side effects, including:
  • Injection-related effects, steroid-related effects and movement of the implant.
  • Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.
  • You may experience temporary blurred vision. Do not drive or use machines until your vision clears.
  • The most common side effects in the eye were cataract and increased pressure in the eye. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.
  • If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.
Please see full Prescribing Information for YUTIQ at yutiq.com/pi/.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

This site is intended for US residents only. YUTIQ is a registered trademark of Alimera Sciences, Inc.

CONTINUOUS CALM and CONTINUOUS MICRODOSING are trademarks of Alimera Sciences, Inc.

Copyright © 2024 Alimera Sciences, Inc. All rights reserved. 1-844-445-8843. US-YTQ-MMM-0029

References

  1. YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg full US Prescribing Information.
    Alimera Sciences, Inc. June 2023.

References

  1. What is Uveitis?. Prevent Blindness. Updated June 21, 2021. Accessed November 28, 2023. 

https://preventblindness.org/wp-content/uploads/2021/06/FS119-Uveitisshort.pdf